EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Drug–Drug Interaction Signals for Major Bleeding in Nursing Home Residents: High‐Throughput Screening of Clopidogrel and Oral Anticoagulants

Adam M D'Amico, Melissa R Riester, Charles E Leonard iD, Daniel A Harris, Lori A Daiello, Yu-Chia Sam Hsu iD, Douglas P Kiel, Meghan A Cupp iD, Kaleen N Hayes iD, Andrew R Zullo

Pharmacoepidemiology and Drug Safety · 2026

DOI: 10.1002/pds.70441 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmacoepidemiology and Drug Safety, 2026. Verfasst von Adam M D'Amico und 9 weiteren Autor:innen. Beteiligte Einrichtung: Center for Gerontology and Health Care Research, Brown University School of Public Health, Providence, Rhode Island, USA. Hauptthemen laut MEDLINE: Clopidogrel, Anticoagulants, Hemorrhage. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIA NIH HHS, National Institute on Aging.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Nursing home (NH) residents are at high risk for major bleeding and are frequently exposed to complex medication regimens that may increase the likelihood of clinically important drug–drug interactions (DDIs). However, DDI evidence from community‐dwelling populations may not generalize to NH residents, and real‐world signals involving clopidogrel and oral anticoagulants remain incompletely characterized in this setting. We aimed to identify and interpret candidate DDI signals for major bleeding involving clopidogrel and oral anticoagulants among NH residents.

Methods

Using linked Minimum Data Set assessments and Medicare fee‐for‐service claims (2013–2020), we conducted high‐throughput, self‐controlled case series (SCCS) screening analyses for four object drugs (clopidogrel, apixaban, rivaroxaban, and warfarin) paired with candidate precipitant medications. We estimated rate ratios (RRs) and 95% confidence intervals (CIs) comparing periods of concomitant use versus object drug use alone, applying semi‐Bayes shrinkage to reduce false‐positive signals. To aid interpretation, we incorporated two negative controls: a negative‐control object drug (pravastatin) and a negative‐control outcome (fall‐related injury). A panel of experts evaluated signals for biological plausibility and potential bias.

Results

After semi‐Bayes adjustment, 5/40 clopidogrel, 1/29 apixaban, 2/15 rivaroxaban, and 6/22 warfarin signals remained significant, and none did for pravastatin. Signals were also observed for fall‐related injury. Experts identified only clopidogrel/sertraline and warfarin with cephalexin, sulfamethoxazole‐trimethoprim, and furosemide as biologically plausible signals.

Conclusion

SCCS screening for DDIs in NH residents identified bleeding signals for clopidogrel and oral anticoagulants, but few were mechanistically coherent and fall‐related injury signals suggested residual bias.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ClopidogrelAnticoagulantsHemorrhageHumansDrug InteractionsNursing Home ResidentsFemaleMalePlatelet Aggregation InhibitorsHigh-Throughput Screening AssaysAged, 80 and overAgedAdministration, OralUnited StatesWarfarinNursing HomesPyrazolesPyridonesRivaroxaban

Stichwörter der Autor:innen

anticoagulantsclopidogreldrug–drug interactionshigh‐throughput screeningnursing homeolder adults

Substanzen

ClopidogrelAnticoagulantsPlatelet Aggregation InhibitorsWarfarinPyrazolesapixabanPyridonesRivaroxaban

Autor:innen und Institutionen

  • Center for Gerontology and Health Care Research, Brown University School of Public Health, Providence, Rhode Island, USA.
  • Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Department of Epidemiology, College of Health Sciences, University of Delaware, Newark, Delaware, USA.
  • Department of Neurology, Warren Alpert Medical School, Brown University, Providence, Rhode Island, USA.
  • Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Hinda and Arthur Marcus Institute for Aging Research, Hebrew SeniorLife, Boston, Massachusetts, USA.
  • Department of Epidemiology, Brown University School of Public Health, Providence, Rhode Island, USA.

ORCID-Profile: Charles E Leonard, Yu-Chia Sam Hsu, Meghan A Cupp, Kaleen N Hayes

Förderung

  • NIA NIH HHS
  • National Institute on Aging

Zitieren

APA

D'Amico, A. M., Riester, M. R., Leonard, C. E., Harris, D. A., Daiello, L. A., Hsu, Y. S., Kiel, D. P., Cupp, M. A., Hayes, K. N., & Zullo, A. R. (2026). Drug–Drug Interaction Signals for Major Bleeding in Nursing Home Residents: High‐Throughput Screening of Clopidogrel and Oral Anticoagulants. Pharmacoepidemiology and Drug Safety. https://doi.org/10.1002/pds.70441

Vancouver

D'Amico AM, Riester MR, Leonard CE, Harris DA, Daiello LA, Hsu YS, et al. Drug–Drug Interaction Signals for Major Bleeding in Nursing Home Residents: High‐Throughput Screening of Clopidogrel and Oral Anticoagulants. Pharmacoepidemiology and Drug Safety. 2026. doi:10.1002/pds.70441

BibTeX
@article{DAmico2026,
  author = {D'Amico, Adam M and Riester, Melissa R and Leonard, Charles E and Harris, Daniel A and Daiello, Lori A and Hsu, Yu-Chia Sam and Kiel, Douglas P and Cupp, Meghan A and Hayes, Kaleen N and Zullo, Andrew R},
  title = {Drug–Drug Interaction Signals for Major Bleeding in Nursing Home Residents: High‐Throughput Screening of Clopidogrel and Oral Anticoagulants},
  journal = {Pharmacoepidemiology and Drug Safety},
  year = {2026},
  doi = {10.1002/pds.70441}
}
Kostenlos starten →